Jade Biosciences, Inc. (JBIO)

NASDAQ: JBIO · Real-Time Price · USD
12.48
+2.48 (24.80%)
May 2, 2025, 4:00 PM EDT - Market closed
24.80%
Market Cap 402.30M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 32.24M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 235,465
Open 10.50
Previous Close 10.00
Day's Range 10.50 - 13.29
52-Week Range 9.02 - 884.98
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jun 2, 2025

About JBIO

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts. [Read more]

Founded 2024
Country United States
Stock Exchange NASDAQ
Ticker Symbol JBIO
Full Company Profile

News

There is no news available yet.